Sunday, November 15, 2026

International Finance

5 articles

Hong Kong VC Deals Triple as State Fund Targets AI Infrastructure, Challenging Singapore

Hong Kong VC Deals Triple as State Fund Targets AI Infrastructure, Challenging Singapore

Hong Kong's venture capital ecosystem recorded its highest deal activity in over a decade in 2025, with transaction volume tripling as the government-backed Hong Kong Investment Corporation partnered with local fund managers. The recovery centers on AI infrastructure, logistics tech, and longevity ventures, positioning the city to reclaim Asian market share lost to Singapore and mainland Chinese hubs during the pandemic freeze.

ViaNews Editorial Team•
Iran Strikes Send Global Energy Prices Soaring as Central Banks Face Stagflation Dilemma

Iran Strikes Send Global Energy Prices Soaring as Central Banks Face Stagflation Dilemma

Iranian attacks on energy infrastructure across nine countries drove European gas prices up 85% and oil past $80 per barrel, creating simultaneous inflation and recession risks. The Fed faces pressure to coordinate with Treasury on its $7 trillion balance sheet, echoing debates about central bank independence during the 1951 Fed-Treasury Accord. Markets from Seoul to New York tumbled on stagflation fears.

ViaNews Editorial Team•
Gas Prices Jump 85% After Iran Strikes Energy Sites, Fed Policy Shift Threatens Global Banks

Gas Prices Jump 85% After Iran Strikes Energy Sites, Fed Policy Shift Threatens Global Banks

Iranian strikes on energy infrastructure drove European natural gas prices up 85% and oil above $80, while proposed Federal Reserve policy changes add pressure on banks worldwide. Korean markets fell 12% and the S&P 500 dropped 2.5% as energy shocks collided with monetary uncertainty. Banks from Seoul to Frankfurt face dual risks from energy credit exposure and potential Fed-Treasury coordination that would reshape $7.7 trillion in central bank operations.

ViaNews Editorial Team•
Norwegian Investors Risk $500M Total Loss as Chinese Salmon Farm Gets 'Catastrophic' Biosecurity Rating

Norwegian Investors Risk $500M Total Loss as Chinese Salmon Farm Gets 'Catastrophic' Biosecurity Rating

Nordic Aqua's $500 million land-based salmon facility in Ningbo, China faces catastrophic biosecurity risk that could wipe out entire production from a single disease outbreak. The recirculating water system creates amplified pathogen transmission in high-density conditions, threatening Norwegian investors' capital and China's push for aquaculture self-sufficiency.

ViaNews Editorial Team•
UK Gilt Markets Face Triple Shock as Fed Leadership Transition Threatens Dollar Stability

UK Gilt Markets Face Triple Shock as Fed Leadership Transition Threatens Dollar Stability

UK Chancellor Rachel Reeves confronts narrowing fiscal space ahead of Spring Statement 2026 as gilt yields remain volatile. Federal Reserve Chair Jerome Powell's May 2026 term expiry creates monetary policy uncertainty while US Social Security faces 2032 insolvency, threatening cross-border banking stability and dollar-denominated assets held by UK financial institutions.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source, and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,580 source documents archived
Query this data → isubstrate.com